Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2025 20:26 ET | Source: Robbins LLP

Robbins LLP Reminds Investors of the Pending Class Action Against Cassava Sciences, Inc. and Urges SAVA Stockholders to Contact the Firm for Information

Robbins LLP is Investigating Allegations that Cassava Sciences, Inc. (SAVA) Misled Investors Regarding its Lead Drug Candidate
January 02, 2025 15:34 ET | Source: Robbins LLP

Robbins LLP Reminds Investors of the Cassava Sciences, Inc. (SAVA) Class Action and Urges Investors with Large Losses to Contact the Firm for Information

Robbins LLP is Investigating Allegations that Cassava Sciences, Inc. (SAVA) Misled Investors Regarding its Lead Drug Candidate
December 19, 2024 20:09 ET | Source: Robbins LLP

Cassava Sciences, Inc. Stockholder Alert: Robbins LLP Reminds Investors of the SAVA Class Action

Robbins LLP is Investigating Allegations that Cassava Sciences, Inc. (SAVA) Misled Investors Regarding its Lead Drug Candidate